Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease

Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation

Lancet Neurol.

Latourelle JC, Beste MT, Hadzi TC, Miller RE, Oppenheim JN, Valko MP, Wuest DM, Church BW, Khalil IG, Hayete B, Venuto CS

doi: 10.1016/

Parkinson’s Disease

Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease

JAMA Neurol.

De Pablo-Fernández E, Lees AJ, Holton JL, Warner TT

doi: 10.1001/jamaneurol.

Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease: A Randomized Clinical Trial

JAMA Neurol.

Bond AE, Shah BB, Huss DS, Dallapiazza RF, Warren A, Harrison MB, Sperling SA, Wang XQ, Gwinn R, Witt J, Ro S, Elias WJ

doi: 10.1001/

Predicting progression in patients with Parkinson's disease

Lancet Neurol.

Blauwendraat C, Bandrés-Ciga S, Singleton AB

doi: 10.1016/

Aging and Cognitive FunctionsAnxiety and Depression

Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts

Lancet Neurol.

Liu G, Locascio JJ, Corvol JC, Boot B, Liao Z, Page K, Franco D, Burke K, Jansen IE, Trisini-Lipsanopoulos A, Winder-Rhodes S, Tanner CM, Lang AE, Eberly S, Elbaz A, Brice A, Mangone G, Ravina B, Shoulson I, Cormier-Dequaire F, Heutink P, van Hilten JJ, Barker RA, Williams-Gray CH, Marinus J, Scherzer CR

doi: 10.1016/

Parkinson’s DiseaseAnxiety and Depression

Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study

Lancet Neurol.

Martínez-Fernández R, Rodríguez-Rojas R, Del Álamo M, Hernández-Fernández F, Pineda-Pardo JA, Dileone M, Alonso-Frech F, Foffani G, Obeso I, Gasca-Salas C, de Luis-Pastor E, Vela L, Obeso JA

doi: 10.1016/

Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.

JAMA Neurol.

Schapira AH, Fox SH, Hauser RA, Jankovic J, Jost WH, Kenney C, Kulisevsky J, Pahwa R, Poewe W, Anand R

doi: 10.1001/jamaneurol.

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

Lancet Neurol.

Katzenschlager R, Poewe W, Rascol O, Trenkwalder C, Deuschl G, Chaudhuri KR, Henriksen T, van Laar T, Spivey K, Vel S, Staines H, Lees A

doi: 10.1016/S1474-

Aging and Cognitive Functions

Correlation of Visuospatial Ability and EEG Slowing in Patients with Parkinson's Disease

Parkinsons Dis.

Eichelberger D, Calabrese P, Meyer A, Chaturvedi M, Hatz F, Fuhr P, Gschwandtner U

doi: 10.1155/2017/3659784.

Related content

Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation

Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease

Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease: A Randomized Clinical Trial

Predicting progression in patients with Parkinson's disease

Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts

Focused ultrasound subthalamotomy in patients with asymmetric Parkinson's disease: a pilot study

Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

Correlation of Visuospatial Ability and EEG Slowing in Patients with Parkinson's Disease